Search Results - "Zhiltsova, E.  K. "

Refine Results
  1. 1

    Current approaches to systemic treatment of BRCA-associated triple-negative breast cancer by Enaldieva, D. A., Krivorotko, P. V., Imyanitov, E. N., Zhiltsova, E. K., Donskikh, R. V., Shaikhelislamova, L. F., Gigolaeva, L. P., Semiglazov, V. F.

    Published in Uspehi molekulârnoj onkologii (07-10-2023)
    “…BRCA -associated triple-negative breast cancer (TNBC) is characterized by high sensitivity to DNA-damaging cytotoxic drugs. The use of well-known BRCA1/2…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Utility of dual-energy contrast-enhanced spectral mammography for the diagnosis of multicentric breast cancer by Chyornaya, A. V., Ulyanova, R.  Kh, Krivorotko, P.  V., Artemyeva, A. S., Bagnenko, S. S., Zhiltsova, E. K., Novikov, S. N., Danilov, V. V., Krzhivitskiy, P.  I., Semiglazov, V. F.

    Published in Opukholi zhenskoĭ reproduktivnoĭ sistemy (19-01-2022)
    “…Background . Breast cancer (BC) can be unifocal, multifocal, multicentric (MCBC) and bilateral according to number and localization of tumors. MCBC has…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER by Krivorotko, P. V., Zhiltsova, E. K., Gigolaeva, L. P., Khadzhimatova, Sh. M., Dashyan, G. A., Zernov, K. Yu, Trufanova, E. S., Artemyeva, А. S., Kudaibergenova, A. G., Semiglazov, V. F.

    Published in Opukholi zhenskoĭ reproduktivnoĭ sistemy (01-12-2017)
    “…Background. Breast cancer is a heterogeneous disease with a variety of phenotypic forms. Triple-negative breast cancer (TNBC) is one of the most aggressive…”
    Get full text
    Journal Article
  10. 10

    NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER by Semiglazov, V. F., Semiglazov, V. V., Dashyan, G. A., Krivorotko, P. V., Ivanov, V. G., Zhiltsova, E. K., Paltuev, R. M., Bershtein, L. M., Semiglazova, T. Yu, Yerechshenko, S. S., Klimenko, V. V., Apollonova, V. S., Komyahov, A. V., Bessonov, A. A.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (04-07-2018)
    “…More than 70 % of patients with breast cancer have estrogen-receptor-positive tumors (ER+) and are considered hormone- sensitive. That is why a vast majority…”
    Get full text
    Journal Article
  11. 11

    PHOTODYNAMIC THERAPY FOR INTRADERMAL METASTASES OF BREAST CANCER USING THE MATRIX LIGHT-EMITTING DIODES APPARATUS LATUS by Gelfond, M L, Ivanov, V G, Semiglazov, V F, Vorotnikov, V V, Belousova, T A, Zhiltsova, E K, Ivanova, O A, Ermilova, E V, Fedosov, S I

    Published in Voprosy onkologij (2015)
    “…There are presented results of photodynamic therapy (PDT) for patients with chemo- and radioresistant intradermal metastases of breast cancer using the matrix…”
    Get more information
    Journal Article
  12. 12

    AUTOLOGOUS TRANSPLANTATION OF ADIPOSE TISSUE IN RECONSTRUCTIVE AND PLASTIC SURGERY. NEW POSSIBILITIES OF "OLD" MATERIAL by Ivanov, V G, Fedosov, S I, Ermilova, E V, Volokh, M A, Zhiltsova, E K, Ivanova, O A, Semiglazov, V F

    Published in Voprosy onkologij (2015)
    “…The work is devoted to the methods of application of own adipose tissue as a plastic material and presents the summary of the currently known data on the use…”
    Get more information
    Journal Article
  13. 13

    Expression of estrogen receptors-beta and aromatase activity in primary mammary gland tumors by Bershtein, L M, Zimarina, T S, Poroshina, T E, Kovalevskii, A Yu, Tsyrlina, E V, Zhiltsova, E K, Semiglazov, V F

    “…Expression of estrogen receptors alpha and beta was studied by the PCR method in 22 primary receptor-positive or receptor-negative breast carcinomas obtained…”
    Get full text
    Journal Article
  14. 14

    Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy by Bershtein, L M, Poroshina, T E, Zimarina, T S, Tsyrlina, E V, Zhil'tsova, E K, Kovalevskii, A Yu, Semiglazov, V F

    “…We studied the content and expression of mRNA for estrogen receptors-alpha and -beta in breast tumors before and after 3-month neoadjuvant hormone therapy with…”
    Get full text
    Journal Article
  15. 15

    Own experience of indocyanine green use in the diagnosis and treatment of breast cancer in N.N. Petrov NMRC of Oncology by Tabagua, T T, Krivorotko, P V, Levchenko, V E, Pesotsky, R S, Amirov, N, Zhiltsova, E K, Krzhivitskiy, P I, Semiglazov, V F

    Published in Hirurgija (Moskva) (2024)
    “…To evaluate the possibility of using the method of sentinel lymph nodes (SLN) detection with indocyanine green (ICG) in patients with early breast cancer and…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases by Dashyan, G. A., Semiglazov, V. F., Krivorot’ko, P. V., Semiglazova, T. Yu, Topuzov, E. E., Paltuev, R. M., Zernov, K. Yu, Apollonova, V. S., Ereshchenko, S. S., Petrova, A. V., Zhil’tsova, E. K., Ivanova, O. A.

    Published in Opukholi zhenskoĭ reproduktivnoĭ sistemy (01-06-2016)
    “…Brain metastases are detectable in 25–35 % of patients with progressive HER-2-positve breast cancer. Even after spreading metastases into the brain,…”
    Get full text
    Journal Article
  19. 19

    New prospects in the use of Kadcyla® in breast cancer by Dashyan, G. A., Semiglazov, V. F., Krivorot’ko, P. V., Paltuev, R. M., Topuzov, E. E., Semiglazova, T. Yu, Zhil’tsova, E. K., Donskikh, R. V., Tabagua, T. T., Apollonova, V. S.

    Published in Opukholi zhenskoĭ reproduktivnoĭ sistemy (01-11-2015)
    “…As is known, the HER-2-expressing biological subtype of breast cancer (BC) is characterized by an aggressive course and has a poorprognosis in the absence of…”
    Get full text
    Journal Article
  20. 20